Table 1.
Descriptive statistics by stimulant treatment receipt
| No stimulant tx (n = 66) n (%) |
Stimulant tx (n = 93) n (%) |
Group differences t, p |
|
|---|---|---|---|
| Female | 18 (27.27) | 38 (40.86) | 1.77, 0.08 |
| Male | 48 (72.73) | 55 (59.14) | |
| White | 51 (77.27) | 76 (81.72) | 0.69, 0.49 |
| Non-White | 15 (22.73) | 17 (18.28) | |
| ADHD presentation | |||
| Inattentive | 56 (84.85) | 62 (66.67) | − 2.62, < .01 |
| Combined | 10 (15.15) | 31 (33.33) | |
| Any internalizing diagnosis | 21 (31.82) | 31 (33.33) | 0.20, 0.84 |
| Any externalizing diagnosis | 16 (24.24) | 16 (17.2) | − 1.09, 0.28 |
| Current sleep medication | 6 (9.09) | 24 (25.81) | 2.70,0 < .01 |
| Current SSRI medication | 4 (6.06) | 13 (13.98) | 1.59, 0.11 |
| Current other depression/anxiety medication | 0 (0) | 3 (3.23) | 1.47, 0.14 |
| Current antipsychotic medication | 0 (0) | 3 (3.23) | 1.47, 0.14 |
| Current other medication | 1 (1.52) | 1 (1.08) | − 24, 0.81 |
| M (SD) | M (SD) | t, p | |
| ADHD diagnosis age | 8.50 (2.30) | 7.89 (2.65) | − 1.09, 0.28 |
| ADHD medication initiation age | 9.37 (2.06) | 8.25 (2.64) | − 1.94, 0.06 |
| Family income | 84,394 (32,951) | 84,565 (38,026) | 0.03, 0.98 |
Tx treatment. M mean. SD standard deviation. Note: statistically significant group differences are bolded